What is the address of Dr. Heyman Mieke Pediater?

The registered office of Dr. Heyman Mieke Pediater is located at Achterhoek 13, 8581 Avelgem.

Is Dr. Heyman Mieke Pediater still active?

Yes. According to the CBE (29 September 2026) Dr. Heyman Mieke Pediater is active, legal situation “Normale toestand”, started on 2 May 2011.

Is Dr. Heyman Mieke Pediater registered on Peppol?

Yes, Dr. Heyman Mieke Pediater is registered on the Peppol network with ID 0208:0835922145.

What is the enterprise number of Dr. Heyman Mieke Pediater?

The enterprise number of Dr. Heyman Mieke Pediater is BE0835922145.

When was Dr. Heyman Mieke Pediater founded?

Dr. Heyman Mieke Pediater was founded on 2 May 2011.

Who are the directors of Dr. Heyman Mieke Pediater?

According to the 2025 annual accounts, the directors of Dr. Heyman Mieke Pediater are: Mieke Heyman.

Is Dr. Heyman Mieke Pediater a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 2 May 2011; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Dr. Heyman Mieke Pediater make in 2025?

Dr. Heyman Mieke Pediater posted a profit after taxes of € 112,738 in financial year 2025.

What is the revenue of Dr. Heyman Mieke Pediater?

As a small company, Dr. Heyman Mieke Pediater is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 189,429.

Dr. Heyman Mieke Pediater (Private Limited) - Avelgem

Dossier Dr. Heyman Mieke Pediater, printed on 29 September 2026 from databakkes.be/en/0835922145/dr-heyman-mieke-pediater. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 41 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

Dr. Heyman Mieke Pediater from Avelgem, company number BE0835922145, closed financial year 2025 with a result of € 112,738 after tax. For that financial year Dr. Heyman Mieke Pediater recorded a gross margin of € 189,429 and equity of € 711,560. Compared with financial year 2024, the result moved from € 68,387 to € 112,738. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 7, 2026.

What it is worth Growing

€ 711,560

▲ 19% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 112,738

▲ 65% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 132,633

▼ 35% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 699,160.

People and assets in 2025

Vehicles and equipment

€ 33,530

▼ 18% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 13 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 164,850

▼ 7% vs 2024

€ 12,600 is repaid this year. At this pace the long-term loan is gone in ≈ 13 years.

Owed to suppliers

€ 2,628

▼ 42% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 21,166

▲ € 17,309 vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 185,286 Gross margin 2022: € 185,286 First fiscal year in the series	€ 73,918 Gross margin 2023: € 73,918 ▼ 60% vs 2022 (€ 185,286) Unfavourable step	€ 130,883 Gross margin 2024: € 130,883 ▲ 77% vs 2023 (€ 73,918) Favourable step	€ 189,429 Gross margin 2025: € 189,429 ▲ 45% vs 2024 (€ 130,883) Favourable step	▲ 45%
Profit after taxes	€ 92,495 Profit after taxes 2022: € 92,495 First fiscal year in the series	€ 25,492 Profit after taxes 2023: € 25,492 ▼ 72% vs 2022 (€ 92,495) Unfavourable step	€ 68,387 Profit after taxes 2024: € 68,387 ▲ 168% vs 2023 (€ 25,492) Favourable step	€ 112,738 Profit after taxes 2025: € 112,738 ▲ 65% vs 2024 (€ 68,387) Favourable step	▲ 65%
Equity	€ 1,454,620 Equity 2022: € 1,454,620 First fiscal year in the series	€ 949,784 Equity 2023: € 949,784 ▼ 35% vs 2022 (€ 1,454,620) Unfavourable step	€ 598,822 Equity 2024: € 598,822 ▼ 37% vs 2023 (€ 949,784) Unfavourable step	€ 711,560 Equity 2025: € 711,560 ▲ 19% vs 2024 (€ 598,822) Favourable step	▲ 19%
Total debts	€ 300,529 Total debts 2022: € 300,529 First fiscal year in the series	€ 272,384 Total debts 2023: € 272,384 ▼ 9% vs 2022 (€ 300,529) Favourable step	€ 663,354 Total debts 2024: € 663,354 ▲ 144% vs 2023 (€ 272,384) Unfavourable step	€ 480,864 Total debts 2025: € 480,864 ▼ 28% vs 2024 (€ 663,354) Favourable step	▼ 28%
Cash	€ 400,682 Cash 2022: € 400,682 First fiscal year in the series	€ 80,435 Cash 2023: € 80,435 ▼ 80% vs 2022 (€ 400,682) Unfavourable step	€ 204,797 Cash 2024: € 204,797 ▲ 155% vs 2023 (€ 80,435) Favourable step	€ 132,633 Cash 2025: € 132,633 ▼ 35% vs 2024 (€ 204,797) Unfavourable step	▼ 35%
Land & buildings	€ 692,729 Land & buildings 2022: € 692,729 First fiscal year in the series	€ 682,992 Land & buildings 2023: € 682,992 ▼ 1% vs 2022 (€ 692,729) Unchanged	€ 657,565 Land & buildings 2024: € 657,565 ▼ 4% vs 2023 (€ 682,992) Unchanged	€ 645,187 Land & buildings 2025: € 645,187 ▼ 2% vs 2024 (€ 657,565) Unchanged	▼ 2%
Retained profit	€ 1,442,220 Retained profit 2022: € 1,442,220 First fiscal year in the series	€ 937,384 Retained profit 2023: € 937,384 ▼ 35% vs 2022 (€ 1,442,220) Unfavourable step	€ 586,422 Retained profit 2024: € 586,422 ▼ 37% vs 2023 (€ 937,384) Unfavourable step	€ 699,160 Retained profit 2025: € 699,160 ▲ 19% vs 2024 (€ 586,422) Favourable step	▲ 19%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 530,329 Dividend 2023: € 530,329 Unchanged (€ 0) Unchanged	€ 419,348 Dividend 2024: € 419,348 ▼ 21% vs 2023 (€ 530,329) Unchanged	€ 0 Dividend 2025: € 0 ▼ 100% vs 2024 (€ 419,348) Unchanged	▼ 100%
Bank debt	€ 202,650 Bank debt 2022: € 202,650 First fiscal year in the series	€ 190,050 Bank debt 2023: € 190,050 ▼ 6% vs 2022 (€ 202,650) Favourable step	€ 177,450 Bank debt 2024: € 177,450 ▼ 7% vs 2023 (€ 190,050) Favourable step	€ 164,850 Bank debt 2025: € 164,850 ▼ 7% vs 2024 (€ 177,450) Favourable step	▼ 7%
Balance sheet total	€ 1,755,150 Balance sheet total 2022: € 1,755,150 First fiscal year in the series	€ 1,222,167 Balance sheet total 2023: € 1,222,167 ▼ 30% vs 2022 (€ 1,755,150) Unchanged	€ 1,262,177 Balance sheet total 2024: € 1,262,177 ▲ 3% vs 2023 (€ 1,222,167) Unchanged	€ 1,192,424 Balance sheet total 2025: € 1,192,424 ▼ 6% vs 2024 (€ 1,262,177) Unchanged	▼ 6%

Key figures of Dr. Heyman Mieke Pediater, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dr. Heyman Mieke Pediater?

What happened at Dr. Heyman Mieke Pediater in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 7, 2026 New annual accounts for financial year 2025: profit of € 112,738 (▲ 65% vs 2024). filed late Source: NBB ↗
May 2, 2011 New establishment in Avelgem. KBO
May 2, 2011 Start of the company according to the CBE. KBO

In short

From € 92,495 profit in 2022 to € 112,738 profit in 2025.

Paid € 137,276 in corporate taxes since 2022.

Best year ever: 2025, with € 112,738 profit.

Paid out € 949,677 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Dr. Heyman Mieke Pediater? We notify you, reason included.

Follow Dr. Heyman Mieke Pediater

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Mieke Heyman

Dr. Heyman Mieke Pediater

Behind Dr. Heyman Mieke Pediater is Mieke Heyman.

See the full network in the app

Directors

According to the 2025 annual accounts

Mieke Heyman

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Achterhoek 13

8581 Avelgem

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0835.922.145
VAT number: BE 0835.922.145
Registered office: Achterhoek 13, 8581 Avelgem
Names & denominations: Dr. Heyman Mieke Pediater
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 2 May 2011
Peppol: Active · Active since 24 Aug 2025

View on CBE Public ↗ Annual accounts (NBB) ↗